Open research questions in Cardiac electrophysiology and arrhythmias
449 gap statements mined from Cardiac electrophysiology and arrhythmias papers in our 7.9M-paper local library, which holds 2,383 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Cardiac electrophysiology and arrhythmias? See the ranked Medicine journals.
What the literature leaves open
The lack of multi-channel modeling in the field of cardiac ion channel QSAR. The understudy of secondary channels, such as Kv7.1, Kv4.3, and Kir2.1. The absence of standardized evaluation infrastructure against which progress could be measured.
We have not established the methods to measure free calcium ion concentrations in HAP and therefore cannot provide such data for aficamten. We have not measured the effects of aficamten on skinned human atrial fibres. A direct study of the effects of aficamten on left ventricle muscle strips remains a task ahead.
The gap identified by the paper is the lack of knowledge about the effects of Aficamten on isolated human cardiac preparations. Prior work has focused on the effects of Aficamten on animal cardiac preparations or on its binding properties to myosin.
Managing arrhythmias in critically ill patients with limited cardiovascular reserve. Balancing the benefits and risks of pharmacological treatment, including the potential side effects of amiodarone. The technical challenges of catheter ablation, including the need for multiple imaging modalities.
Further studies are needed to fully understand the pathophysiological mechanism and the interrelationship between SCD and chronic obstructive pulmonary disease (COPD). Research on the potential determining factors such as chronic systemic inflammation that occurs with advancing age and the development of several chronic diseases is needed.
Is Lung Disease a Risk Factor for Sudden Cardiac Death? A Comparative Case–Control Histopathological Study · 2025 · DOIThe pathophysiological mechanism and the interrelationship between sudden cardiac death and chronic obstructive pulmonary disease is not fully known. There is a need to examine the histopathological changes in cardiac and pulmonary tissues in individuals who died from sudden cardiac death.
Is Lung Disease a Risk Factor for Sudden Cardiac Death? A Comparative Case–Control Histopathological Study · 2025 · DOIThe link between a disease and sudden cardiac death remains not fully explained. The diagnostic process of channelopathies has not been fully developed. The genetic and molecular aspects of channelopathies are complex and not fully understood.
Despite early characterization of mutations in selectivity filter of other Na V isoforms, little is known about the impact of DE E A on Na V 1.
The diagnostic implications of a positive epinephrine challenge for long QT syndrome (LQTS) or catecholaminergic polymorphic ventricular tachycardia (CPVT) are not well understood.
The clinical significance of accentuation of precordial J-point elevation during exercise in Brugada syndrome (BrS) remains unclear.
Prevalence and Prognostic Significance of Exercise-Accentuated J-Point Elevation in Brugada Syndrome · 2026 · DOICatheter ablation has emerged as a treatment option in patients with recurrent VAs, yet the extent and reliability of its long-term benefit remain debated.
B-6 | Meta-Analysis on Radiofrequency Ablation to Reduce Ventricular Arrhythmia in Brugada Syndrome · 2026 · DOIWhile conditions, such as heart failure and Duchenne muscular dystrophy, are associated with increased detyrosination of microtubules and reduced sodium current, a potential role for microtubule detyrosination in arrhythmogenic cardiomyopathy has not been explored.
Decreasing Microtubule Detyrosination Improves Cardiac Mechanics and Sodium Channel Function in Arrhythmogenic Cardiomyopathy · 2026 · DOIParent PYRs are known to exert cardiotoxic effects by enhancing the late sodium current (I Na-L) and inducing arrhythmia, but the direct effect of 3-PBA on heart excitability has not been previously investigated.
The Pesticide Pyrethroid Metabolite 3-Phenoxybenzoic Acid (3-PBA) Impairs Human Cardiac Nav1.5 and Action Potential Depolarization · 2026 · DOIWhile epidemiological data consistently link urinary 3-PBA to increased cardiometabolic risk and coronary heart disease, the underlying electrophysiological mechanisms of its direct potential cardiotoxicity remain unexplored.
The Pesticide Pyrethroid Metabolite 3-Phenoxybenzoic Acid (3-PBA) Impairs Human Cardiac Nav1.5 and Action Potential Depolarization · 2026 · DOIThis study was limited by the use of male mice, and the causal contribution of elevated ROS to the observed SAN dysfunction was not directly tested.
Excess accumulation of intracellular lipid droplet impairs sinoatrial function in a mouse model of myocardial steatosis · 2026 · DOIDedicated trials are warranted to clarify causality, dose-dependency, and the therapeutic potential of microRNA-SGLT2i interactions for arrhythmia prevention and management in high-risk populations.
Cardiac Electrophysiological Impact of Sodium Glucose Cotransporter 2 Inhibitors: A Comprehensive Review · 2026 · DOIWhile t-tubule restoration is therefore an ideal therapeutic target, atrial t-tubule development is not well understood.
Atrial t-tubules adopt a distinct developmental state as Ca2+ handling matures postnatally · 2026 · DOIOur findings suggest that JPH2 abundance alone is insufficient to preserve T-tubule integrity in failing human hearts and challenge the role of JPH2 in human disease.
Junctophilin-2 abundance is unaltered in human heart failure samples with disrupted T-tubules and contractility · 2026 · DOIHowever, human-level data on JPH2's role in heart failure remain sparse, particularly regarding its protein abundance and functional relevance in human disease, which is imperative for validating therapeutic target selection.
Junctophilin-2 abundance is unaltered in human heart failure samples with disrupted T-tubules and contractility · 2026 · DOIWhile the transcriptional programs underlying CCS development and function have been studied within individual species, how these programs compare across species and developmental stages remains unclear.
Conservation and divergence of transcriptional heterogeneity in the cardiac conduction system · 2026 · DOIThe precise electrophysiological mechanisms underlying arrhythmogenesis in HCM, particularly in the context of MYBPC3 truncating mutations, remain incompletely defined, hindering the development of targeted therapies.
Electrophysiological remodeling in the hypertrophic cardiomyopathy MYBPC3 R943X mutant in human iPSC-derived cardiomyocytes and modulation by IKto-targeting drugs · 2026 · DOIInvestigating whether statistically discernible differences are associated with specific study design choices or modeling era, - Building reliable multi-channel pipelines for TdP risk…
Extending the model to diseased backgrounds and patient-specific hiPSC-CMs, - Investigating the impact of the complex cardiac MPS experimental configuration and conditions on the vanoxerine-induced response, - Evaluating the safety and efficacy of novel compounds using cardiac…
Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential · 2025 · DOIThe link between a disease and sudden cardiac death remains not fully explained - The lack of the patient's clinical phenotype and poor accessibility to the patient's family history create the problem of misdiagnosis - Genetic testing should be carried out in highly specialized cardiovascular genomics centers to avoid interpretation…
These findings identify myocardial steatosis as a previously underrecognized contributor to SAN dysfunction.
Excess accumulation of intracellular lipid droplet impairs sinoatrial function in a mouse model of myocardial steatosis · 2026 · DOI
Most-cited papers in Cardiac electrophysiology and arrhythmias
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction · New England Journal of Medicine · 1989 · 2,778 citations
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts · New England Journal of Medicine · 1982 · 1,809 citations
- Drug-Induced Prolongation of the QT Interval · New England Journal of Medicine · 2004 · 1,634 citations
- Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death · American Journal of Psychiatry · 2001 · 670 citations
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) · JAMA Cardiology · 2020 · 522 citations
- An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome · Circulation · 2020 · 377 citations
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19) · Mayo Clinic Proceedings · 2020 · 315 citations
- Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation · Circulation Research · 2020 · 290 citations
- 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families · Heart Rhythm · 2020 · 285 citations
- Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes · Drug Safety · 2002 · 264 citations
Most recent work
- Fronto-insular circuit mechanisms of accelerated intermittent theta burst stimulation · Cell · 2026
- T-World Virtual Human Cardiomyocyte. I. Development, Validation, and Cell Arrhythmogenesis · Circulation Research · 2026
- SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death · European Heart Journal · 2026
- Symbiotic transcatheter pacemaker for lifelong energy regeneration and therapeutic function in porcine disease model · Nature Biomedical Engineering · 2026
- Human‐derived cardiac‐neural microtissues reveal catecholaminergic polymorphic ventricular tachycardia is also a disease of the sympathetic neuron · The Journal of Physiology · 2026
- An automated computational pipeline for generating large-scale cohorts of patient-specific ventricular models in electromechanical in silico trials · Computer Methods and Programs in Biomedicine · 2026
- Cardiac Screening for Conditions Associated With Sudden Cardiac Death · Journal of the American College of Cardiology · 2026
- Panoramic voltage‐sensitive optical mapping of contracting hearts using cooperative multiview motion tracking with 12 cameras · The Journal of Physiology · 2026
- Spatial modulation on spiral waves in memristive cardiac tissue · Communications in Nonlinear Science and Numerical Simulation · 2026
- Intercalated disk structure, tissue heterogeneity and ion channel distribution modulate conduction and local calcium influx · The Journal of Physiology · 2026
Find a gap in your own Cardiac electrophysiology and arrhythmias sub-topic
This page shows what the Cardiac electrophysiology and arrhythmias literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →